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Title: Prehabilitation for adults diagnosed with cancer: a systematic review of long-term physical 
function, nutrition and patient reported outcomes 
 
Abstract:  
Prehabilitation is increasingly being used as an intervention to mitigate treatment-related 
complications and enhance recovery. An individual’s state of health at diagnosis including; obesity, 
physical fitness and comorbidities, are influencing factors for the occurrence of adverse effects. This 
review explores whether prehabilitation works in improving health outcomes at or beyond the initial 
30-days post treatment and considers the utility of prehabilitation before cancer treatment. A database 
search was conducted for articles published with prehabilitation as a pre cancer treatment intervention 
between 2009-2017. Studies with no 30-day post treatment data were excluded. Outcomes post 
prehabilitation were extracted for physical function, nutrition and patient reported outcomes. Sixteen 
randomised controlled trials with a combined 2017 particpants and six observational studies with 289 
particpants were included. Prehabilitation interventions provided multi-modality components 
including exercise, nutrition and psycho educational aspects. Prehabilitation improved gait, cardio 
pulmonary function, urinary continence, lung function and mood 30-days post treatment but was not 
consistent across studies. When combined with rehabilitation, greater benefits were seen in 30 day 
gait and physical functioning compared to prehabilitation alone. Large scale randomized studies are 
required to translate what is already known from feasibility studies to improve overall health and 
increase long-term cancer patient outcomes. 
 
 
Key words: Prehabilitation, Rehabilitation,Cancer, Exercise, Nutrition, Survivorship 
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Title: Prehabilitation for adults diagnosed with cancer: a systematic review of long-term physical 
function, nutrition and patient reported outcomes 
 
 
Introduction 
Prehabilitation offers a route to improving patient’s physical status and buffering treatment-related 
deconditioning between the time of cancer diagnosis and post treatment recovery. Prehabilitation 
includes physical and psychological assessments that establish baseline functioning and identify 
impairments that can impact on cancer treatment-related morbidity, as well as providing targeted 
interventions to maximize patient function prior to treatment onset (Silver and Baima, 2013). The 
primary goal of prehabilitation is “to prevent or reduce the severity of anticipated treatment-related 
impairments that may cause significant disability (page2) (Silver and Baima, 2013). There are several 
systematic reviews of prehabilitation for those receiving cancer surgery (Boereboom et al., 2016, 
Carli et al., 2017, Singh et al., 2013) and all suggest that prehabilitation enhances early discharge from 
hospital and reduces surgical adverse effects. There is a growing requirement to include 
prehabilitation as part of the cancer pathway with three recent reports advising the value of 
prehabilitation, two in the USA (National Academies of Sciences, 2018, Stout et al., 2016) and one in 
the UK (Macmillan Cancer Support, 2018). However evidence that prehabilitation translates into 
better long-term patient outcomes beyond the initial 30-day post treatment complications is lacking. 
 
Challenges to providing prehabilitation are that cancer patients are highly likely to have comorbidities 
that complicate treatment delivery and reduce physical fitness (Sarfati et al., 2016, Stairmand et al., 
2015). Comorbid conditions associated with aging and particularly excess body weight are common 
in patients presenting with cancer (Goodwin and Chlebowski, 2016) and evidence from 
epidemiological studies suggests that comorbidities and poorer health are correlates of poorer survival 
(Land et al., 2012, Land et al., 2012). There is compelling evidence for the link between obesity and 
cancer outcomes (Calle  et al., 2003) with particular associations in the following tumour sites breast 
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(Jiralerspong and Goodwin, 2016), gastrointestinal (Brown and Meyerhardt, 2016), endometrial 
(Onstad et al., 2016), prostate (Vidal et al., 2014) as well as haematological cancers, including 
multiple myeloma and leukaemia (Yang et al., 2016). Obesity is an important risk factor for 
cardiovascular, kidney disease, diabetes and some musculoskeletal disorders (Collaboration). These 
obesity-related comorbidities contribute to the adverse effects of cancer treatment (Bradley et al., 
2014, Søgaard et al., 2013) and combined with an aging demographic, where more than 60% of 
cancer patients are over 65, comorbidity and poorer physical and functional health will impact upon 
future cancer treatment delivery and outcomes (Greenlee et al., 2016). These co exisiting health 
problems are strong indicators for providing prehabilitation to maximise cancer treatment outcomes. 
Rehabilitation interventions such as exercise, weight reduction and pharmacotherapy are recognised 
ways of managing comorbity-related conditions after cancer treatment (Alamuddin et al., 2016) and 
there is evidence that smoking cessation (Sitas et al., 2014) reduces adverse treatment effects and 
improves survival. Preparing patients prior to cancer therapy by improving their overall health status 
as in prehabilitation could optimise their response to treatment and has important implications for 
future service delivery (Silver and Baima, 2013). Prehabilitation has been espoused as a key 
component of early recovery in cancer patients and is a term that has been traditionally used to 
describe interventions for optimising cardiopulmonary reserve prior to cancer surgery, with the aim of 
improving post-operative recovery outcomes (Carli et al., 2017, Silver, 2015, Silver and Baima, 
2013). However, prehabilitation programs are also targeting this pre-treatment period to improve 
chemotherapy adherence (Le Roy et al., 2016), reduce anxiety (Tsimopoulou et al., 2015), and to 
provide a stronger platform for post-treatment rehabilitation aimed at reversing treatment-related side 
effects and symptoms, managing comorbidities and enhancing longer-term health-related quality of 
life (Alfano et al., 2012, Boereboom et al., 2015, Shun, 2016, Silver, 2014). While fewer studies have 
been undertaken outside of the surgical context, a growing number of studies are focusing on different 
cancer treatments and modes of prehabilitation using exercise, psychological support and nutritional 
interventions. These studies need to look at longer-term outcomes beyond the traditional enhanced 
recovery 30-day post treatment outcomes, to understand treatment adherence, mortality, disease 
Page 3 of 37
European Journal of Cancer Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 4 
prognosis or impact on health economics (Stout et al., 2018). This is the first systematic review to 
critically review the impact of different prehabilitation interventions on long-term health outcomes (at 
or beyond 30-days post-treatment completion) in cancer patients and explore the utility of 
prehabilitation as a platform for risk management before and after all cancer treatments.  
This review addressed two questions: 
1. What is the effect of prehabilitation on > 30 day post treatment outcomes including; physical 
functioning, nutrition and patient-reported outcomes ? 
2. How can prehabilitation be used to optimise the management of cancer patients with 
comorbidity or pre-existing risk factors that are associated with poorer cancer treatment 
outcomes? 
 
 
Methods  
Data Sources and search method 
The review was registered on PROSPERO (CRD42016050296) international prospective database of 
systematic reviews. The search was conducted in two stages. In stage one, studies were identified via 
abstracts through a systematic search strategy for Medline (Pub med), CINAHL (with full text) 
Embase and Cochrane central register of controlled trials. The databases were chosen to identify 
potentially relevant published studies in the field of medicine, exercise, health and psychosocial care. 
Search terms were split into two categories “prehabilitation combined with cancer” and terms to 
identify the nature of prehabilitation such as “exercise, nutrition, psychology and other behavioural 
interventions”. The full search strategy and MESH terms are provided in supplementary materials. In 
stage two, other relevant publications were retrieved by reviewing the reference lists of these studies 
against the eligibility criteria.  
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Studies selected were published from the period 2000 to February 2017. The following were all 
excluded from the review; prehabilitation studies with no reported post-treatment outcomes at 30-days 
or longer; studies that combined data from previously published studies; abstracts, case studies, 
conference abstracts and those not in English. Participants included were cancer patients who were 
treated with any treatment modality and received any form of prehabilitation either in the home or 
hospital setting. Prehabilitation was defined as a single or multi-modality intervention that could 
include exercise, nutritional support, patient education and/or psychological therapy. Control was 
defined as those participant’s receiving usual care as defined in the clinical pathway. Identification of 
objective clinical, patient reported and delivery outcomes were described at 30-days post treatment 
completion.  Comorbidity data at baseline and at completion were also reviewed. Efficacy in relation 
to 30 day post treatment objective physical functioning was explored through meta-analysis but data 
was not of sufficient quality to make a comparison. The quality of eligible studies was assessed using 
the PRISMA critical appraisal methods (Shamseer L et al., 2015). Risk of bias was assessed by an 
interdisciplinary research team using the Cochrane Collaboration’s tool for assessing risk of bias 
ROBINS-I tool (Sterne et al., 2016). Observational or quasi-experimental studies were included as 
they provided additional information as to the use of prehabilitation interventions. 
 
Results 
Sixteen randomised controlled trials (RCT) and six observational studies were included in the 
narrative synthesis (Figure 1). The quality of the RCT studies varied considerably with 7 of the 16 
studies being considered as having a high risk of bias. Studies were not sufficiently consistent in 
intervention or outcome data to be included in a meta-analysis. In many studies reporting of the 
randomization processes, lack of allocation concealment to those enrolling, blinding of outcome 
assessors and poor reporting of missing data may have impacted on study quality (Table 1). Most 
studies were single centre studies. However, one of two multi-site studies was a 3-arm trial comparing 
psychological prehabilitation strategies, with participants randomized to stress management, a support 
group or usual care (Parker et al., 2009). Other studies compared different prehabilitation components 
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head to head as nutritional interventions or psychological approaches. The number of participants 
within the RCTs ranged from 48 to 652, with a median of 88 with a total number of subjects in the 
review of 2017 (Table 1). Most individual RCTs analysed fewer than 60% of the sample originally 
recruited in the study, excluding participants due to comorbidity or inability to undergo cardio 
pulmonary exercise testing. Participants were adults with colorectal (Carli et al., 2010, Cheville et al., 
2015, Gillis et al., 2014, Gillis et al., 2016, Moriya, 2015) lung (Barlési et al., 2008, Stefanelli et al., 
2013), head and neck (Van Bokhorst-de Van der Schuer et al., 2000), breast (Garssen et al., 2013), 
bladder (Jensen et al., 2015, Jensen et al., 2014) and prostate (Bales et al., 2000, Burgio et al., 2006, 
Parker et al., 2009) cancer or included individuals with a range of cancers (Schmidt et al., 2015). Trial 
designs were primarily feasibility studies and therefore the studies were rarely powered to determine 
the efficacy of prehabilitation on post-treatment recovery outcomes. The primary endpoint was 
predominantly objective physical function prior to treatment with the secondary endpoints described 
at 1 to 6 months post intervention. Only four (25%) of the authors fully reported participant 
comorbidities at baseline (Burgio et al., 2006, Jensen et al., 2015, Schmidt et al., 2015, Van Bokhorst-
de Van der Schuer et al., 2000) whilst two actively excluded participants with comorbidities possibly 
due to the intensity of the exercise programme (Carli et al., 2010, Stefanelli et al., 2013). 
The designs of the 6 observational studies were either case controlled cohort, historical controls or 
quasi experimental. Studies were primarily feasibility studies and participant numbers were small, 
ranging from 35 to 87 with a total of 289 particpants.  Studies included individuals with breast cancer 
(Baima et al., 2015), lung cancer (Jones et al., 2007, Peddle et al., 2009, Sekine et al., 2005), 
colorectal cancer (Li et al., 2013) and prostate cancer (Sueppel et al., 2001).  
Comorbidities were only reported in three of the studies at baseline, with ill health being cited as a 
contributing factor to difficulties with recruitment rather than this being recorded as an outcome. 
Several studies did not report attrition (Sekine et al., 2005, Sueppel et al., 2001), and among those that 
did attrition rates ranged from 0 to 52%. The number and combination of prehabilitation modalities 
varied considerably across studies, ranging from 1 to 3 across individual RCTs and observational 
studies (Table 2 & 3).   
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Most (16/22) studies included an exercise modality, either as a stand-alone prehabilitation intervention 
or in combination. Four studies examined the effects of pelvic floor training in men with prostate 
cancer over a varying number of weeks before radical prostatectomy (Bales et al., 2000, Burgio et al., 
2006, Centemero et al., 2010, Sueppel et al., 2001). These were predominantly home-based exercise 
programmes with some level of instruction and supervision and/or biofeedback training. Two studies 
incorporated supervised therapeutic pulmonary exercises (in conjunction with more conventional 
conditioning exercise) in lung cancer patients in the 2-3 weeks prior to surgery (Sekine et al., 2005, 
Stefanelli et al., 2013). These exercises were performed on 5-7 days per week and included incentive 
spirometry, abdominal breathing, huffing and coughing, and respiratory exercises on a bench, 
mattress pad and wall bars. Finally, a study in breast cancer patients investigated the feasibility of 
therapeutic shoulder mobility exercises in the 2-4 weeks before surgery, comparing in-person teaching 
with video-only teaching (Baima et al., 2015). Both methods were shown to be feasible with high 
adherence (≥75%). Other studies investigated the effects of conventional forms of exercise 
conditioning for improving cardiopulmonary fitness and/or muscular strength over durations of 2-8 
weeks, though most programmes were of 2-4 weeks duration (Table 2 & 3). All but one of these 
studies implemented exercise prehabilitation in the time period before colorectal, lung or bladder 
cancer surgery, whereas the remaining study (Cheville et al., 2015) focused on adherence to chemo 
radiotherapy in patients with gastrointestinal cancers. Home-based programmes generally consisted of 
aerobic and resistance exercise on at least three days per week with varying degrees of face to face 
supervision and telephone support (Carli et al., 2010, Gillis et al., 2014, Jensen et al., 2015, Jensen et 
al., 2014, Li et al., 2013). Instructions on both the frequency and intensity of aerobic exercise were 
generally provided and in some cases participants used heart rate monitors and perceived exertion 
scales to self-assess their level of effort (Gillis et al., 2014, Li et al., 2013). Studies of more closely 
supervised 2-6 week programs of exercise prehabilitation involved vigorous intensity cycle ergometry 
in lung (Jones et al., 2007, Peddle et al., 2009) and rectal cancer patients (West et al., 2015) prior to 
surgery and isokinetic muscle strengthening exercises in patients with gastrointestinal cancers during 
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chemo radiotherapy (Cheville et al., 2015). Two further studies included vigorous gym-based aerobic 
exercise (Stefanelli et al., 2013) or walking exercise (5000 steps/day)(Sekine et al., 2005) in 
combination with therapeutic pulmonary exercises in patients with lung cancer prior to surgery. The 
short timelines prior to therapy made a progressive programme difficult to achieve. Although 
adherence to the home exercise program was reported in most of these studies, adherence to exercise 
at the prescribed intensity and progression of the exercise programme were poorly reported.  
 
Only five of the studies provided a nutritional modality as part of the prehabilitation package. Some 
of the interventions were purely nutrition based (Gillis et al., 2016, Moriya, 2015, Van Bokhorst-de 
Van der Schuer et al., 2000), however, two of the studies used nutrition as part of multi-component 
prehabilitation intervention (Gillis et al., 2016, Li et al., 2013). The nutritional interventions were 
varied with 5-10 days preoperative feeding plus a supplemental arginine formula (Van Bokhorst-de 
Van der Schuer et al., 2000) or whey protein (Gillis et al., 2014, Li et al., 2013) or a low or high dose 
immune-enhancing diet (Moriya, 2015). Multi-modal prehabilitation interventions provided 90-min of 
nutritional counselling with daily whey protein supplementation (Gillis et al., 2016) in comparison to 
a control group which received nutritional counselling without supplementation. The timing of 
nutritional interventions varied between 5-10 days (Gillis et al., 2016, Moriya, 2015) and 3-6 weeks 
pre-operatively (Gillis et al., 2014, Li et al., 2013). The nutritional intervention did not continue 
beyond surgery, with one exception (Gillis et al., 2016) which continued the nutritional intervention 4 
weeks’ post-surgery. Nutritional therapies were primarily targeted on individuals with cancer who 
were malnourished, receiving treatment for head and neck (Van Bokhorst-de Van der Schuer et al., 
2000) or colorectal cancer (Gillis et al., 2014, Gillis et al., 2016, Li et al., 2013, Moriya, 2015). Van 
Bokhorst (Van Bokhorst-de Van der Schuer et al., 2000) excluded adults from the study if they were 
well nourished (10% excluded), whereas Gillis (Gillis et al., 2016) screened for malnutrition using the 
Patient Generated – Subjective Global Assessment (PG-SGA) which is a validated tool for nutritional 
assessment in oncology. Adherence to nutritional intervention is reported in only one study with 
researchers contacting participants on a weekly basis to encourage them to record their whey protein 
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ingestion. This study noted that adherence was higher in the prehabilitation group compared to the 
rehabilitation group both pre and post-surgery. 
 
Studies involving a psychoeducation modality as part of prehabilitation programmes have focused 
primarily on anxiety and stress reduction(Cheville et al., 2015, Garssen et al., 2013, Parker et al., 
2009, Schmidt et al., 2015), patient education and lifestyle advice (Baima et al., 2015, Barlési et al., 
2008) (Jensen et al., 2015) and/or counselling (Parker et al., 2009) as part of the intervention; 
however, few studies report any detail of the therapeutic components of the intervention. Psycho 
educational prehabilitation strategies have been studied as single mode counselling interventions 
(Barlési et al., 2008, Cheville et al., 2015) or by comparing a variety of psychological and educational 
approaches prior to cancer treatment (Parker et al., 2009). Psycho educational strategies have also 
been studied as part of multi component prehabilitation programmes (Gillis et al., 2014, Jensen et al., 
2015, Jensen et al., 2014). Psycho educational interventions prior to surgery for lung and 
gastrointestinal cancer provided written and verbal information to participants which described the 
disease and associated surgery outcomes (Barlési et al., 2008, Schmidt et al., 2015). An alternative 
psycho therapeutic approach involved weekly group sessions with a psychiatrist, focused on 
individuals’ social, cognitive and emotional care in conjunction with relaxation exercises 30-days 
prior to chemotherapy(Cheville et al., 2015). Similarly, Garsen (Garssen et al., 2013) provided 4 
sessions over 5 days to women with breast cancer, including stress management, relaxation, guided 
imagery techniques and counselling. Parker(Parker et al., 2009) investigated the effects of a similar 
programme on post-operative recovery outcomes in men with prostate cancer.  These interventions 
were all compared to usual or supportive care. Adherence to the intervention was not always reported 
in the observational studies with attrition 25-52% respectively (Baima et al., 2015) (Jones et al., 
2007). 
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Objective clinical outcomes following prehabilitation  
Studies that included an exercise modality investigated the effects of prehabilitation regimens on 
cancer treatment recovery outcomes and cardiopulmonary fitness (table 4). Three studies reported 
favourable effects of home-based pelvic floor training on post-operative urinary continence outcomes 
in prostate cancer patients undergoing radical prostatectomy up to 12 months of follow-up (Burgio et 
al., 2006, Centemero et al., 2010, Sueppel et al., 2001) and a fourth study (Bales et al., 2000) showed 
no urinary continence benefits of including biofeedback training. Similarly, a study of female breast 
cancer patients reported no additional post-operative benefits when home-based shoulder exercise 
prehabilitation included an in-person teaching session versus video-based instruction (Baima et al., 
2015). Supervised exercise prehabilitation programmes in lung cancer patients have generally been 
more intensive than home-based programmes and have resulted in improvements in pre-operative 
cardiopulmonary fitness measures, including six minute walk test (6MWT) (Jones et al., 2007) and 
peak VO2 (Jones et al., 2007, Stefanelli et al., 2013). However, the improvements in peak VO2 were 
modest (2-3 ml kg min-1) and it is unclear whether improvements of this magnitude translate to 
improved post-operative recovery outcomes or longer-term outcomes, such as quality of life. It is of 
interest to note that intensive cycle ergometry prehabilitation had no impact on quality of life pre-
surgery or at 2-months post surgery (Peddle et al., 2009). Nevertheless, Sekine (Sekine et al., 2005) 
reported a reduction in post-operative pulmonary complications and hospital length of stay in lung 
cancer patients after a prehabilitation programme that involved daily pulmonary therapeutic exercises 
and walking (5000 steps/day) in the two weeks prior to lobectomy when compared to historical 
controls. In other studies, prehabilitation programs involving exercise have yielded equivocal results. 
A supervised programme involving cycling + strengthening exercises in patients with gastrointestinal 
cancer compared to those in a walking + breathing exercise group showed no differences in 6MWT 
distance (Carli et al., 2010). Similarly, home-based exercise programs involving aerobic and/or 
resistance exercise 4 weeks prior to surgery have had minimal impact on post-operative hospital 
length of stay or severity of complication (Gillis et al., 2014, Jensen et al., 2015, Jensen et al., 2014), 
although Jensen (Jensen et al., 2015) reported improved post-operative 6MWT distance in bladder 
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cancer patients receiving prehabilitation, 4806m (95%CI 4075m-5536m) compared to 2906m (95%CI 
2408-3404m) in those receiving usual care. Gillis (Gillis et al., 2014) reported higher submaximal 
cardiopulmonary fitness + 23.4m (6MWT) in a prehabilitation/ rehabilitation group compared to 
rehabilitation alone -21.8m (80.7) at 8 weeks after colorectal cancer surgery. 
 
Studies that included nutritional outcomes were few and reported no significant differences between 
the intervention and control groups at >30 days (Moriya, 2015) on post treatment physical functioning 
(table 4). However, preoperative nutritional modality groups showed a significant improvement in 
physical functioning and initial symptoms post operatively (Gillis et al., 2014, Li et al., 2013, Van 
Bokhorst-de Van der Schuer et al., 2000). Only one study measured upper-body strength (Gillis et al., 
2016) and this improved pre-surgery but was not sustained post-surgery.  Participants who received 
arginine supplementation with feeding pre-and post-surgery showed reduced appetite at 6 months 
(Van Bokhorst-de Van der Schuer et al., 2000) and serum albumin remained stable in a small (n=17) 
pre-post intervention study (Li et al., 2013). However, prehabilitation studies nutritional outcomes are 
compromised by the lack of consistency in measuring nutritional intake and adherence (mainly 
through self-report tools) or objective sarcopenia measures. Such limitations could have important 
implications for assessing treatment fidelity and the sensitivity of outcome measures. 
 
Patient reported outcomes (PRO) of prehabilitation  
PRO in the studies reviewed included health related quality of life using the Short Form Health 
Survey (SF36) and Prostate Cancer Index (PCI), which incorporate physical and emotional subscales. 
Symptom specific measures such as the International Continence Scale for men (ICS male), the 
Hospital Anxiety and Depression Scale (HADs) and (PCI) and Activities of Daily Living (ADL) tool 
were also reported in some studies (Table 4). Quality of life scores were comparable between 
prehabilitation and control groups at 3 months post-intervention in most studies (Barlési et al., 2008, 
Burgio et al., 2006, Garssen et al., 2013, Peddle et al., 2009). However, in two studies, self-reported 
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physical function was higher in the prehabilitation group at 1 year (Li et al., 2013, Parker et al., 2009) 
and in the study by Li (Li et al., 2013), an increase in self-reported physical activity persisted 8 weeks 
after surgery.  Post-treatment improvements in mood, anxiety and depression have been reported 
immediately post-operatively following prehabilitation involving walking + breathing exercises and 
psychological support (Carli et al., 2010, Parker et al., 2009, Schmidt et al., 2015) but effects were 
small and between group differences were not sustained long-term (Parker et al., 2009, Schmidt et al., 
2015). Behavioural change techniques, such as smoking cessation, were rarely reported in studies, this 
can impact on radiotherapy side-effects and subsequent post-treatment cancer outcomes (Warren et 
al., 2014). 
 
Patient reported and service outcomes for prehabilitation  
Complication rates and length of hospital stay post-surgery were the most frequent service delivery 
measures reported for >30-days post treatment (Table 4). There was no difference in length of stay, 
between prehabilitation and control groups in five studies (Gillis et al., 2014, Gillis et al., 2016, 
Jensen et al., 2014, Li et al., 2013, Schmidt et al., 2015), with the exception of Sekines (Sekine et al., 
2005), where the intervention group had a reduced length of stay after a 4-6 week prehabilitation 
program. Post-operative complications such as wound healing, seroma formation and bleeding were 
shown to be comparable between intervention and control groups but Moriya (Moriya, 2015) found 
that those receiving a prehabilitation nutritional intervention had fewer post-operative site infections . 
Prehabilitation has been shown to improve initial post-operative mobilisation (Jensen et al., 2015) and 
the number of patients completing chemotherapy (Cheville et al., 2015). Furthermore, in the latter 
study, those receiving the intervention had significantly fewer treatment hospitalisations. 
 
Discussion  
Overall this systematic review suggests prehabilitation impacts on select 30-day outcome measures 
for some people with cancer but few studies have measured or reported overall long-term health 
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benefits. The results of the review are summarised pictorially as a diagram describing the multi-
modality intervention and linked physical function, nutrition and patient reported outcomes used in 
the reviewed studies (Figure 2). Many of these studies report service or process data measures such as 
length of stay and post-operative complications, but do not consistently capture changes in physical 
functioning or patient reported outcomes.  The only exception is pre-operative therapeutic pelvic floor 
exercises for men undergoing prostatectomy for prostate cancer where prehabilitation improved long-
term urinary continence.  This reflects the differentation between general prehabilitation versus 
targeted exercise or nutrition interventions and the greater specificity of their effect. There is 
insufficient evidence for demonstration of long-term benefits in other cancer patient populations 
beyond the initial 30 day post treatment complications. Even vigorous intensity pre-operative aerobic 
exercise conditioning programmes have only resulted in modest improvements in peak oxygen uptake 
pre-operatively (of the order of 2-3 ml/kg/min-1), possibly a factor of the short duration of programs, 
and these gains are lost post-operatively. Not surprisingly then, prehabilitation combined with 
rehabilitation was the most effective approach in improving outcomes longer than 30-days.  
 
It is now recognised that a physically active lifestyle is inversely related to the risk of certain cancers 
and mortality (Brown JC et al., 2012, Schmid and Leitzmann, 2014). Surprisingly few prehabilitation 
studies measured or reported participant comorbidities and how they changed over time. Therefore we 
were unable to address our second question, how prehabilitation can optimise the management of 
cancer patients with comorbidity? Comorbidities in participants in prehabilitation studies were 
considered exclusion criteria rather than as predictors of physical functioning that could be mediated 
by exercise or nutrition and that could change as a response to intervention (Brown JC et al., 2012). 
Those participants with high levels of comorbidities and poor fitness were often not eligible to be 
included, which suggests those people most in need to improve physical function were less likely to 
receive prehabilitation. The multi-modality approach of prehabilitation could optimise the 
management of cancer patients with low baseline scores and who have been shown to gain greater 
benefits (Minnella et al., 2016). Rather than trying to demonstrate the efficacy of multi-modality 
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prehabilitation on the fittest patients, we should consider using the approach to optimise the 
management of the more complex and least fit cancer patients who have most to gain. This requires 
more sophisticated tailoring of intervention to personalise and target prehabilitation. For example, 
current exercise guidelines for cancer survivors recommend muscle strengthening exercises for 
overall conditioning (Schmitz KH et al., 2010) but this may not be sufficient to manage specific 
deficits. A more task-specific approach incorporating functional movements using strength and 
mobility may be optimal for prehabilitation regimens (Winters-Stone et al., 2015). 
 
In some studies, the high attrition of participants suggests a balance is required between intensity and 
duration of exercise to be able to meet the needs of those with greater limitations. This highlights the 
need for continuity and support in establishing exercise habits and expectations around exercise for 
people with cancer (Brown JC et al., 2012, Mayo et al., 2011). The content of exercise programmes is 
poorly described in some papers, and have not followed the FITT principle of reporting Frequency, 
Intensity, Timing and Type of exercise and/or how the exercise programme is personalised or 
progressed over time (Thompson et al., 2010).  These oversights make it challenging to understand 
whether or not the exercise program was insufficiently designed and/or how to revise programs to 
optimize adherence and outcomes in the future. 
The inclusion of nutritional support as part of prehabilitation improved short-term physical function. 
The pre-surgical interventions were necessarily short (2-3 weeks) primarily due to treatment target 
times.  Indications from one study suggest that longer term patient outcomes could benefit with 
additional post-surgical rehabilitation. Given the rising proportion of cancer patients who are obese at 
diagnosis, the prehabilitive and rehabilitative window is potentially an opportunity to embed new 
lifestyle behaviours.  Malnutrition is associated with a poorer response to cancer treatment and 
hypoalbuminaemia is associated with post-surgical mortality, increased morbidity and length of stay 
(Hu W-H et al., 2015). Patients with colorectal cancer are more malnourished than other patients 
groups  (28% colorectal compared to 4% prostate cancer) (Hu W-H et al., 2015) hence the wide 
number of prehabilitation studies in this population. In the nutrition components of prehabilitation 
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programs surrogate measures were used for the combined interventions rather than specific targets 
such as, serum values or anthropometric measures. If we are tackling obesity in cancer and its risks, 
then a greater focus on adiposity, fat distribution and sarcopenia should be included in prehabilitation 
studies. With emerging therapies and earlier diagnosis techniques, for example of low dose 
computerised imaging in lung cancer (Smith et al., 2017), the opportunitiy for prehabilitation becomes 
more feasible as patients are less likely to be burdened by advanced disease or chronic illness.  
 
Understanding how prehabilitation components work together is a challenge as few studies used a 
theoretical or conceptual frameworks to guide design. Exploring how the multi-modality components 
work; such as exercise, nutrition, psychoeducational components is essential to maximize outcomes 
(Figure 2). The use of factorial research designs in future studies is recommended in evaluating 
prehabilitation components (Montgomery et al., 2003). Whilst pre-operative exercise programmes 
have incorporated both aerobic and resistance training, most emphasis has been on aerobic exercise. 
The effect of resistance exercise on pre-operative muscular function and how this impacts upon post-
operative recovery outcomes has received less attention (Singh et al., 2013). The relationship between 
psychological health and exercise behaviour has been well established. Short and long term adherence 
may be optimized if anxiety and depression are also addressed during an exercise program, however 
the focus on anxiety and depression management at the expense of evidence based behaviour change 
strategies may not be the best strategy for long-term adherence (Stacey FG et al., 2015).  
A limitation of this review is that conclusions have to be considered in the context of a limited 
number of studies, the majority of which are underpowered feasibility studies. The importance of 
feasibility studies is recognized in the Medical Research Council (MRC) complex interventions 
framework and that they should now be used to inform fully powered RCTs. The review highlighted 
the need for improved quality of studies for example following consort or strobe reporting guidance 
and this has also been described in previous prehabilitation systematic reviews (Singh et al., 2013). 
It’s imperative that future studies take a more ambitious approach to test efficacy by building on the 
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current evidence base using a conceptual framework to guide intervention design and robust 
evaluation.  
 
Can prehabilitation programmes impact on longer-term cancer health outcomes? The answer is 
currently unclear especially in relation to changing comorbiditiy. Prehabilitation is now an integral 
part of many cancer surgical preparatory pathways as part of early recovery but there is scope for 
greater targeting to include nutrition and psychoeducational components, as well as considering how 
prehabilitative interventions may buffer symptoms such as fatigue and pain during adjuvant therapies. 
Sophisticated research designs incorporating economic evaluation and longer-term measures are 
essential to guide service development and support implementation if the concept of cancer 
prehabilitation is to emulate cardiac rehabilitation services. 
 
In conclusion, prehabilitation strategies may have an important role to play in addressing the rising 
complexity of health needs of those diagnosed with cancer. Forty-percent of all those diagnosed with 
cancer have one co-morbid condition and 15% at least two concurrent health problems (Sarfati et al., 
2016). This systematic review highlights that single and multi-modal prehabilitation programmes are 
feasible and some approaches confer short-term benefits in the post-surgical recovery period. The 
next stage is to design robust efficacy studies to test carefully defined prehabilitative/prehabilitative-
rehabilitative interventions at the time of first cancer treatment (be that surgery, systemic anti-cancer 
therapy or radiotherapy) and measure clinical outcome, PRO, patient benefit and service delivery 
outcomes throughout the care pathway. 
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Figure 1. PRISMA study selection flowchart 
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3. Case study  
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PREHABILITATION INTERVENTION
Exercise modality
• Cardio-pulmonary exercise
• Walking
• Flexibility exercise
• Balance
• Strength exercises
• Targeted exercise e.g. Breathing exercises, pelvic floor 
exercises
Nutrition modality
• Supplementation
• Personalised nutritional counselling e.g. weight loss
• Increase protein intake
• Alcohol reduction advice
Psychosocial and education modality
• Anxiety reduction
• Cognitive behavioural therapy (CBT)
• Enhancing self-efficacy (ACT)
• Smoking cessation
• Patient activation and behavioural change coaching
PHYSICAL FUNCTION MEASURES
Objective mobility
• CPET V02 Peak
• Gait: 6 Minute Walk Test
• Chair rise: Sit to stand
• Grip strength
• Timed up and go 
PATIENT REPORTED OUTCOMES
• QOL
• Hospital Anxiety and Depression 
HADs
• SF36 physical function
• Activities of Daily Living)
NUTRITIONAL MEASURES
• BMI
• Hip to waist ratio
• Serum Albumin 
• Sarcopenia measures
• Self report diet diary
PATIENT BENEFIT
• Reduced disability 
• Independence
• Reduced 
complications and 
adverse events
• Reduced length of 
hospitalisation
• Reduced number of 
falls
• Return to work
• Enhanced activities 
of daily living
Risk factors for 
POORER CANCER 
TREATMENT 
OUTCOME
• Obesity 
• Presence of 
comorbidity
• Older age
• Functional 
impairment
• Multiple symptoms 
PROCESS measures of Prehabilitation 
Participation from population and adherence
Frequency, intensity, timing and type of prehabilitation intervention
Safety considerations (e.g. restrictions, adverse events)
Examples of dimension measures
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Table 1 Risk of bias was assessed by an interdisciplinary research team using the Cochrane Collaboration’s tool for assessing risk of bias 
ROBINS-I tool 
 
Random 
Sequence 
Generation
Allocation concealment Blinding of 
participants and 
personnel
Blinding of 
Incomplete outcome data Selective 
outcome 
reporting
random eg. 
random 
number table, 
computer 
random 
participants and 
investigators enrolling 
participants could not 
forsee assignment 
because one of the 
outcome and the 
outcome 
measurement are 
not likely to be 
influenced by lack 
no missing outcome data, 
reasons for missing data 
similar across groups
study protocol 
available and all 
pre-specified 
outcomes are 
reported in the x Research Design Criteria 1 Criteria 2 Criteria 3 Criteria 4 Criteria 5
Bales, 2000 RCT unclear high unclear unclear low
Burgio, 2006 RCT low high low unclear low
Carli, 2010 RCT Stratified randomisation unclear unclear high multiple imputations low
Centemero, 2010 RCT low low low low low
Gillis, 2014 RCT low low low multiple imputations low
Jensen, 2014 RCT unclear unclear unclear unclear high
Jensen, 2015 RCT low low unclear low low
Stefanelli, 2013 RCT unclear unclear unclear unclear low
Barlesi, 2008 RCT unclear unclear unclear high low
Cheville, 2015 RCT unclear unclear low low low
Garssen, 2013 RCT Block Randomised unclear unclear - block randomizatilow unclear high
Parker, 2009 RCT unclear
adaptive 
unclear low unclear/high low
Schmidt, 2015 RCT Block randomised low unclear unclear high low
Gillis, 2015 RCT low low low low low
Moriya, 2015 RCT low low unclear low low
Van Bokhorst, 2000 RCT unclear unclear low high low
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Table 2 Randomized Controlled Trials (RCTs) of Prehabilitation and critical analysis 
Author and 
date 
Intervention 
description 
Control group 
description 
Sample Follow-up 
after 
intervention 
Attrition Critical analysis 
Bales, 2000 
 
 
Frequency:2-4 weeks 
prior to surgery  
Intensity: nurse-led 
biofeedback,10-15 
repetitions Advised to 
practice 4x per day  
Timing 45 minutes 
Type: pelvic floor 
muscle exercise plus 
biofeedback followed 
by post-op PFM 
exercises 
 
Written and brief 
verbal instructions 
on how to perform 
pelvic floor 
muscle exercises 
 
100 men 
undergoing 
radical 
prostatectomy 
Mean age 
intervention 
60.9yrs and 
control 59.3yrs. 
 
Prostate cancer 
stages T1c-T2c 
 
Comorbidity not 
reported 
Every month 
for 6-months 
post-surgery 
3%  
6%  
 
By 6 months following radical prostatectomy, the incidence of urinary 
continence in the biofeedback and control groups was 94% and 96%, 
respectively. 
 
No difference in patients who received biofeedback pre op and those who did 
not  There was no objective measure, just number of wet diapers (vs weight of 
diaper); unclear about characteristics of those who dropped out, unknown 
pelvic floor muscle strength prior to undertaking study 
 
Barlesi, 2008 
 
Frequency: unclear 
Intensity: unclear 
 
Timing: Prior to 
surgery 
Type: Additional oral 
plus written 
information including 
associated symptoms 
Oral information 
only describing the 
disease and its 
associated surgery 
and outcomes 
75 patients with 
NSCLC 
undergoing 
thoracic surgery 
 
Comorbidity not 
reported 
Baseline and 
3 months 
26% QoL scores (baseline, 3 months) were comparable between both groups.  
Patients receiving oral plus written information were significantly dissatisfied 
related to several aspects of care regarding staff as well as the structure.  
 
The information group significantly influenced satisfaction levels at 
multivariate analysis (standardized beta coefficient, 0.26, p = 0.04). 
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Burgio, 2006 
 
Frequency: initiated 1 
week prior to surgery 
Intensity Daily 45 
pelvic floor exercises 
Timing:  One 
preoperative session  
Type:  biofeedback 
plus assisted 
behavioural training  
Home based exercise 
Usual Care 125 men 
undergoing 
surgery  
 
Mean age 60.9 
+/- 6.9yrs.  
 
Prostate cancer 
 
Comorbidity 
reported  
6 months’ 
post-surgery 
10% At 6 months: 
Difference between the groups in the proportion of men remaining incontinent 
was 20.03% (higher in the intervention group) 
(95% CI 6.02% to 34.63%) (p<0.04).  
 
Severe/continual leakage was still present in 19.6% of controls compared to 
5.9% of those in intervention group (p <0.04).  
 
Intervention group had a  
- higher proportion of dry days (p < 0.04),  
- lower proportion using pads (p <0.05).  
No group differences were found in life-style variables,  
- incontinence impact (p = 0.36,  
- psychological distress (p = 0.69) 
- quality of life (p = 0.31 to 0.89). 
Unclear how long provided and the intensity of the exercises 
Carli, 2010 
 
Frequency: average 52 
days prior to surgery 
Intensity: High 
intensity exercise 
Timing 3 times per 
week 
Type:  Prescribed 
stationary cycling 
(daily) with 
strengthening 
prescribed  
 
Walk/breathing 
group: 
recommendations 
to walk daily and 
perform foot and 
ankle exercises to 
enhance lower-
extremity 
circulation as well 
as breathing 
exercises 
112 patients 
undergoing 
colorectal 
surgery.  
 
Mean age 60 
(SD 16)  
 
Participants 
with 
comorbidities 
grade IV or V 
were excluded 
from study or if 
unable to 
complete testing 
procedure 
10 weeks’ 
post-surgery 
16% Improvement in walking capacity in walk/breathing (47%) vs.  
bike/strengthening pre-surgery (22%). But not sustained over time  
 
Mean peak VO2 improved in both groups: Bike/ strengthening 134 
ml/min (P = 0.003) versus walk breathing 112 ml/min (P = 0.007) 
but not over time.  
 
Anxiety considerably reduced after surgery but did not change in 
either group over the prehabilitation period. 
 
Depression improved for the bike/strengthening group over the 
prehabilitation period.  
 
Exercise participation bike/strengthening group > walk/breathing 
group (P = 0.075). 
 
Lower exercise had better outcomes because of less dropouts, poor 
compliance in the higher intensity group may have been too hard for such 
patients 
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Centemero, 
2010 
 
Frequency: started 30 
days before surgery 2x 
per week 
Intensity: 
Physiotherapist 
encouragement 
Timing: 30 min  
Type: pelvic floor 
muscle exercises at 
hospital and at home 
Postoperative 
pelvic floor 
muscle exercises 
48hrs after 
catheter removal  
118 males 
undergoing 
surgery.  
 
46-68yrs old.  
 
Prostate cancer 
 
Comorbidity not 
reported 
3 months 17% didn’t 
start study 
but were 
eligible 
 
Continence in preoperative group was 59.3% vs. postoperative group 37.3% 
(p<0.028) 
 
ICS male SF mean score in preoperative group 8.1 vs. postoperative 
group 12.2.  
 
Study found that preoperative PFME improved quality of life (The 
ICFS is a symptom based tool) 
 
No detail re adherence to exercises. The question whether the preoperative or 
post-operative had most effect is unclear. Differences persisted for up to 6 
months at 1 year there was no difference. 
Cheville, 2015 
 
Frequency: 2-3X per 
week 
Intensity:  
Timing:(6-8 sessions) 
Type: led by 
psychiatrist included 
social, cognitive, 
emotional care via 
exercise, education 
and relaxation.  
 
Usual care 
 
61 study sample  
 
Women, mean 
age 61.2  
 
Comorbidity not 
reported 
30-day 
readmission 
Not 
reported 
More patients in the intervention completed Chemotherapy (p=0.003) than 
control 
 
Intervention group had significantly fewer treatment hospitalisations 
(p=0.001) 
 
No difference in other measures 
 
There is no data capture on medications or functional health status. No PROM 
outcomes or psychological measures all data capture was through EMR 
retrospective records. 
 
Garssen, 2013 
 
Frequency: 4 sessions 
5 and 1 day prior to 
surgery with session 2 
and 30 days post-
surgery 
Intensity: 
Timing: 40-60 minutes  
Type: Stress 
management training 
delivered by clinical 
psychologist - 
relaxation, guided 
imagery techniques, 
and counselling  
Usual care 70 women 
undergoing 
surgery for 
breast cancer  
 
Intervention 
mean age 52yrs 
control group 
mean age 54 
years  
 
Comorbidity 
partially 
reported (BMI, 
alcohol use) 
30- 90 days 
post-surgery 
18% 
 
Only 57% 
of eligible 
patients 
finished 
study 
At 3 months’ post-surgery compared to baseline, the intervention group had: 
- Significant difference at 1 month in depression  
- no significant difference in quality of life 
- no significant difference in wellbeing 
- pain not measured at 3 months 
- control group more complaints than intervention group 
(0.001<p<0.01).  
At 3-month post-op measures will be affected by start of adjuvant treatment 
(and no information reported on this).  Experience of control measured by 
author designed 4 item questionnaires (un validated measures).  Unable to 
differentiate effect of intervention content or psychologist intervention.  
The study power is not clear against its primary outcome. Targeted 
intervention. The differences between groups at 3 months are not significant. 
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Gillis, 2014 
 
 
 
Frequency: 24 days 3 
days per week 
Intensity: moderate 
aerobic and resistance 
exercises, 
Timing:50 minutes 
Type Home-based 
unsupervised initially 
personalised to the 
individual. Nutrition 
counselling with 
protein 
supplementation 
Coping strategies to 
reduce anxiety and 
promote adherence 
with exercises 
provided on a CD 
 
Rehabilitation 
group or 8 weeks 
post operatively 
(same as 
intervention but 
after surgery) 
 
 
89 patients 
undergoing 
surgery for 
colorectal 
cancer 
 
prehab mean 
age = 65.7 
(13.6); rehab 
mean = 66.0 
(9.1) 
 
Comorbidity 
fully reported 
8 weeks’ 
post-op 
 
13% Difference between baseline and follow-up in prehabilitation group. Mean 
different 45.4m (95% CI, 13.9 to 77.0) 
 
Baseline: Prehab 421m (SD, 120.0) Rehab 425m (SD, 83.8) 
Pre-treatment: Prehab +25.2 (50.2) Rehab -16.4 (46.0) P=0.001 
50% of patients in both groups remained more than 20 m below 
baseline 
 
At 8 weeks, prehab +23.4 (54.8) rehab -21.8 (80.7). P = 0.020 
Complication rates and length of hospital stay were similar in 
prehabilitation and rehabilitation groups. 
 
A change of 20 m is considered clinically meaningful as this is the estimated 
measurement of community dwelling elderly 
 
Limitation of the study is missing data and unclear which modality of 
prehabilitation responsible for outcomes. 
. 
Gillis, 2015 
 
Frequency: 4 weeks 
prior to surgery:  
Intensity:  daily 
intervention 
Timing: 90 min per 
day 
Type: individualised 
nutrition counselling 
with daily whey 
protein 
supplementation  
Individualised 
nutrition 
counselling with a 
non-nutritive 
placebo  
43 patients 
undergoing 
surgical 
treatment.  
 
Mean age 
67.6yrs (sd 
11.5). Mean age 
in placebo 
group (69.1yrs 
(sd 9.4) 
 
Comorbidities 
partially 
reported 
4-8 weeks 
post-op 
10% Before surgery improvement in whey group 20.8m (sd 42.6m) and in placebo 
group (1.2m (sd 65.5m) (p=0.27).  
 
Recovery rates were similar between groups in the 4-weeks post-
surgery (p=0.81). 
Comment: intervention focused on building strength. Focus on upper 
body strength and not lower body. Post intervention lack of nutrition 
may impact on similar group trajectories. 
Pre-surgery results are significant but not sustained at 4 weeks 
 
6MWT data missing pre-op for 4 patients (2 placebo, 2 whey) and 12 post-op 
(4 placebo, 8 whey), analysis based on 32 participants.  If protein required to 
improve muscle functional capacity, presumably protein supplementation 
should be continued post-op for functional capacity to be maintained?  This 
study indicates that effects may only be short-term (i.e. 4 weeks to day of 
surgery, and associated with duration of intervention)  
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Jensen, 2014  
 
Frequency: 2 weeks 
prior to surgery: 
Intensity:15-minute 
step training 
Timing: 2x per day 
Type: Written 
information and 
motivation 
home based  
Pt tailored exercises 
for 6 muscle strength 
and endurance 
 
Standardised 
postoperative 
mobilisation  
Standardised 
nutritional 
screening and 
counselling. 
 
Standardised 
postoperative 
mobilisation was 
encouraged at least 
2x at 30 min day 
129 patients 
undergoing 
radical 
cystectomy 
 
 (analysis based 
on 100 
(intervention 47, 
standard 53) 
 
 
Bladder cancer 
 
Comorbidity 
fully reported 
4 months’ 
post-surgery 
41% There was no significant difference in LOS and number of adverse events.  
Physical capacity was significantly improved (p0.02) and mean 
walking distance at 7 days’ post op.  
 
At follow up both groups had regained physical capacity and no 
difference was seen. 
 
Patient tailored intervention but unclear as to how this was 
personalised Abstract has little information re intervention 
 
Just over half (55%) completed the prehab programme at 100%, 59% fulfilled 
75%.  It would have been useful to compare groups on 6MWT rather than 
LOS as primary outcome measure. 
Jensen, 2015 
 
Frequency: 2 x daily 
Intensity:  progressive 
strength and endurance 
exercises 
Timing daily 
Type:  Preoperative 
home-based 
supervised exercise 
programme and 
postoperative and 
progressive 
postoperative 
mobilization 
 
 
Fast track Patient 
education 
counselling on 
choice of urinary 
intervention, pre-
op preparation, 
pain control and 
nutrition 
 
107 patients 
undergoing 
surgical 
treatment for 
bladder cancer. 
Mean age 
intervention 
group 66yrs, 
mean age 
control group 
71yrs.  
 
Bladder cancer 
 
Comorbidities 
fully reported 
4 months’ 
post-surgery 
 
7% 
attrition 
 
55% 
adherence  
Severity of complications: no significant difference was found in the 
incidence (p = 0.47) or severity (p = 0.64) of complications between the 
treatment groups at 90 days postoperatively, or in readmission within 30 days 
(p = 0.49). 
 
Ability to perform ADL: the median time was 3 days in the intervention 
group, compared with 4 days in the standard group (p < 0.05). 
 
Post-op mobilization: significantly higher in the intervention group, reporting 
4806m walked (95% CI 4075 to 5536 m), compared to the standard group 
with 2906 m walked (95% CI 2408 to 3404 m) (p < 0.001) at 7 days 
 
Significance in 4 month outcomes between groups not seen. 
Page 28 of 37
European Journal of Cancer Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Moriya 2015, 
 
Intervention 1 
Frequency: 5 days 
pre-operatively 
Intensity: High dose 
750ml/ day 
Timing: Daily 
Type: Immune-
enhancing diet (IED) 
(enriched with 
arginine, omega-3 fatty 
acids and RNA) and 
normal food  
 
Intervention 2. 
Intensity: Low-dose 
250ml/day Immune 
enhancing diet 
Control group – 
normal food 
 
88 patients 
undergoing 
surgery for 
colorectal 
cancer 
 
Mean age 
intervention 
64.7 (2.3) 
control 63.8 (2) 
 
 
Comorbidity not 
reported 
9-133 
months after 
surgery 
Not 
reported 
Incisional SSI rates in the IED groups were significantly lower in the 
intervention group than in the Control group. (0%*, 0%* and 17%) (*P<0.01 
vs. Control).  
 
The incidences of the infections not involving the surgical site (non-SSI) and 
the lengths of hospital stay were similar among the three groups. No 
significant differences were observed in RFS or DSS. 
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Parker, 2009 
 
Frequency: 1-2 weeks 
pre-op 
Intensity: 
Timing 2x 60-90 
minute sessions plus 2 
booster sessions on 
morning of surgery 
and 48 hours post-
surgery) 
Type:  
Intervention 1. Stress 
management (SM) 
including 
diaphragmatic 
breathing and guided 
imagery individual 
sessions with clinical 
psychologist,  
 
Intervention 2 
Supportive attention 
(SA) group discussed 
their concerns about 
the upcoming surgery 
and had a semi-
structured medical 
interview.  
Standard care (no 
meetings with 
clinical 
psychologist) 
159 men 
undergoing 
surgery for 
prostate cancer.  
 
Mean age 60.9 
(5.9) 
 
Comorbidities 
not reported 
6-12 months 
post-surgery 
 
34% Post treatment improvements of intervention on mood disturbance (p0.02) 
with the stress management group with no significant differences between 
groups in any of the assessment times between groups over time. 
 
The mixed model analysis targeted therapies. Differences in mood were small 
and although significant are not clinically significant. At 1 year patients had 
better physical function (SF36) but this was self-reported. A targeted 
intervention on those individuals with higher stress may be more beneficial in 
terms of effect size. 
 
Men in SM group had significantly higher physical component summary 
score on SF35 than men is SC group at one year (p=0.0009), but no difference 
in mental component summary score or prostate specific Qol in PCI.  The 
study excluded emotionally distressed men who may benefit from such an 
intervention.   
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Schmidt, 2015 
 
Frequency: 1 day pre-
operatively 
Intensity: 
Timing: 7 days 
Type Information 
booklet lifestyle 
advice, mobilisation, 
nutrition and diary 
keeping 
 
Standard care - 
information 
regarding surgical 
and 
anaesthesiology 
risks and 
procedures 
652 patient’s 
undergoing 
elective surgery 
for gastro-
intestinal, 
genitourinary, 
and thoracic 
cancer 
 
65 years of age 
 
 
Comorbidities 
reported 
3 -12 
months after 
surgery 
15% Complications: Occurrence and severity of complications were comparable in 
both groups, although severe haemorrhage occurred significantly more often 
in the intervention group (6.7% vs. 2.5%; p = 0.01).  
 
LOS: no significant difference between both groups (p = 0.99). 
 
HRQoL: no significant difference between the global HRQoL 12 
months after surgery in the intervention and in the control group. 
 
Postoperative stress: (mobilization, PONV and postoperative pain). 
Patients in the intervention group reported less pain on the first 
postoperative day (75.2% vs. 82.3%, p = 0.03). There were no 
differences regarding mobilization within the first 24 hours (69.2% 
vs. 70.4%, p = 0.73), or PONV within the first five days (52.8% vs. 
56.4%, p = 0.39).  
 
Depression: There was no difference in the geriatric depression scale 
between intervention and control groups at discharge (p = 0.86). 
 
Readmission: The readmission rate within 90 days was slightly 
higher for patients in the intervention group (p = 0.70). In-hospital 
length of stay at readmission was shorter than in the standard care 
group without reaching statistical significance (p = 0.22). 
 
Mortality: The overall mortality did not differ significantly between 
the two groups (Log-Rank-test p = 0.197). 
 
Patient empowerment failed to shorted LOS or HRQOL. This type of 
intervention could enhance quality of care in regards to pain, and since over-
treatment of pain is particularly harmful for elderly patients, patient safely can 
thus be improved. Pre-operative information was received well by patients 
who were cognitively and physically fit. 
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Stefanelli 
2013 
 
Frequency: 3 weeks 
preoperatively 
Intensity:  high-
intensity training 
Timing: 15x3-hour 
sessions weekdays 
Type: outpatient 
intensive pulmonary 
rehabilitation (PRP) 
based on of both 
upper- and lower-limb 
muscles 
 
Control surgery 
according to the 
normal standard 
preoperative 
protocol 
40 NSCL and 
COPD 
undergoing 
lobectomy 
 
Age >75 
 
Excluded 
patients with 
comorbidity 
60 days after 
surgery 
 
Not 
reported 
A significant difference was observed both at T1 and T2. 
In prehabilitation group, peak VO2 improves significantly from T0 to T1, P < 
0.001 and deteriorates from T1 to T2, P < 0.001 in control reverting to a 
similar value to that at T0.  
Control group peak VO2 did not change from T0 to T1 and 
significantly deteriorates from T1 to 
T2: P < 0.00001.  
FEV1 NS  T0, T1, T2 
 
Currently, other studies are needed to demonstrate that the patients who 
undergo preoperative PRP could have also a better quality of life, less 
postoperative complications and a longer survival after surgery. 
Good for CPT VS 6MWT comparison 
Van Bokhorst, 
2000 
 
Frequency: 7-10 days 
pre-operatively plus 14 
days post op 
Intensity: 150% of 
basal energy 
expenditure 
Timing: Daily 
Type: 
1.Standard pre-and 
post-op enteral feeding 
 
2.Arginine 
supplemented pre-op 
and post-op enteral 
feeding 
No pre-op and 
standard post-op 
enteral feeding 
49 malnourished 
head and neck 
cancer patients 
 
Mean age 56.6-
61.6 
 
Comorbidity 
fully reported 
6 months 
post-
surgery. 
37% Between baseline and the day before surgery, both preoperatively fed groups 
revealed a positive change for physical and emotional functioning and 
dyspnoea with significance in arginine group. This was not sustained long 
term at 6 months. 
 
Supplemented group showed a negative change in appetite 
(P=0.049). Between baseline and 6 months after surgery, 
 
There were no differences between control and both pre-fed groups.  
 
There were no differences in favour of Arginine supplement compared to 
other feed group. 
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Table 3 Observational and Quasi Experimental Prehabilitation Studies with critical analysis 
Author, date 
and research 
design 
Intervention and 
comparator 
Population and 
Sample 
 
Follow-
up after 
interven
tion 
Attrition Critical analysis  
Baima, 2015 
 
Feasibility 
study with two 
randomised 
(by 
appointment 
time), non-
blinded groups 
 
 
Timing: 1 month prior to 
surgery. 
Type: In-person teaching of 
exercises plus info sheet, 
plus link to online video 
provided  
 
Comparator 
Video-only teaching arm  
60 cancer patients 
undergoing surgery for 
breast cancer 
1 male, 59 females 
Age 35-81.  
 
(I=36-C24) 
Breast cancer 
 
 
3-mths 
after 
surgery 
 
2 weeks 
to 6 
months 
25% Exercise compliance: 
- 76% chose to exercise.  
- No difference in exercise compliance between in-person teaching versus 
video teaching (OR=1.03). 
In person 75% (24/32) compared to Video teaching 77% (10/13)  
Pain 
- 29% of patients (9/31) had worse shoulder pain than baseline at 1 month 
post-surgery (24 %, 6/25 exercisers, and 50 %, 3/6 non-exercisers). 
- 15% percent of patients (4/27) had worse shoulder pain than baseline at 3 
months’ post-surgery (8 %, 2/23 exercisers, and 100 %, 2/2 non-exercisers). 
Shoulder Abduction 
- 66% of patients (20/30) lost greater than 10% shoulder abduction ROM at 1 
month post-surgery.  
 
Prehabilitation exercise program inferred no additional risk of seroma formation 
(Exercisers 21 %, 7/33 vs. non-exercisers 22 %, 2/9, OR=0.94).  
 
No strong evidence of difference 
 
Single site; Change in intervention based on patient preference, so not random; No 
control group: every participant received some sort of intervention; Stated feasibility 
study, but unclear re: efficacy of  these home exercises; No explanation given for 
why study staff did not pursue missing data; Possible social desirability bias with “in-
person” arm and thus improved compliance; Compliance with exercises self-
reported, possibly participants overestimated;  Unclear description regarding seroma 
formation/evaluation ; Time to follow-up variability (2 weeks – 6 months); 
Lumpectomy and mastectomy included, possibly allowing for very different 
outcomes 
Jones, 2007 
Single group 
design 
feasibility 
study 
 
 
Frequency: 5 endurance 
sessions per week on 
consecutive days until 
surgical resection. .  
Intensity: Highly 
individualised and 
progressive from 60-100% 
VO2 peak, Threshold sessions 
25 patients 70% F 
undergoing surgery for 
suspected lung cancer. 
Mean age 65+/-10years 
 
Lung cancer 
Preoperat
ive 
assessme
nt 
30 days 
post-
surgery 
Attrition 
52% 
 
Adherence 
70% 
For patients who achieved >/=80% adherence (n = 12), VO2 peak increased 3.3 
mL/kg/min (P=0.006). 
Six-minute walk test: Significant improvement in >80% adherence group (p=0.14) 
compared to <80% adherence (p=1.01). 
The overall adherence rate was 72% (range, 0%–100%) with patients completing a 
mean of 30 - 27 sessions (range, 0 - 75). 
No significant difference. (p>0.1) for all measures of pulmonary function 
The average duration of hospital stay was 10 _ 8 days with 8 - 5 days in general 
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and HIIT sessions. 
Timing: Carried out for 4-6 
weeks.  
Type: Cycle ergometry  
 
Comparator: Individually 
tailored intervention and 
hospital based over 4-6 
weeks 
hospital and 2 - 5 days in the intensive care unit.  
No difference in complications or length of stay than in routine patient care. 
The length of intervention may be problematic in a 1-2-week normal wait time for 
surgery, the authors comment on this re the ability to make significant change in such 
a short time. There is no recording of how many patients didn't meet the eligibility 
parameters to reflect the normal practice. 
Li, 2013 
Pre post 
intervention 
study 
 
Historical 
control group 
 
single centre, 
cohort 
Frequency: Individualized 
aerobic exercise (30 mins x3 
times a week,  
Intensity: at 50% of max 
heart rate) and resistance 
training  
Timing: 3 times per week, 
no more detail 
Type, one or two modifiable 
dietary behaviours identified 
and discussed, use of whey 
protein isolate within 1 hour 
of exercise at 1.2g/kg body 
weight per day , 90 minute 
visit with trained 
psychologist with a focus on 
anxiety reduction. Length of 
prehabilitation determined 
by wait time for surgery 
 
87 patients undergoing 
surgery for colorectal 
cancer 
(Control =45 
intervention= 42) 
 
Colorectal cancer 
Assessed 
1 week 
pre op, 4 
weeks 
and 8 
weeks 
post-
surgery 
 
Primary 
outcome 
measure 
6MWT 
@ 8 
weeks 
0% The patients in the prehabilitation program had better postoperative walking capacity 
at 8 weeks (mean difference, 84.5 ± 83 m; p<0.01). At 8 weeks, 81 % of the 
prehabilitated patients were recovered compared with 40 % of the control group 
(p<0.01). 
The prehabilitation group also reported higher levels of physical activity before and 
after surgery. 
The postoperative complication rates and the hospital length of stay were similar. 
There were significant emotional & social differences between control and 
intervention. These are not controlled for in the modelling or analysis of difference. 
Lack of detail re nutritional component. The question of what’s a clinically relevant 
change 
NO data on the length of time of wait for surgery and this would determine the 
amount of time spent on prehabilitation intervention (see column 3).  Historical 
control do not appear to have had baseline assessment, just pre op and 4 and 8 week.  
Could account for difference between groups on HRQoL measures, because pre-op 
measures taken at different times (control taken immediately before surgery; 
intervention after meeting with surgeon).  No tool used to capture functional 
symptoms specific to colorectal cancer e.g. FACT-C, SF35 is too generic.  
Compliance to prehabilitation intervention reported in discussion section (70% 
exercising at least 2 days per week, 45% fully compliant).  Increase in self-reported 
physical activity persisted after surgery. 
Peddle, 2009 
Sub analysis 
of Jones 2007 
Frequency: 5 sessions per 
week on consecutive days 
until surgical resection  
Intensity: Highly 
individualised and 
progressive from 60-100% 
VO2 peak, Threshold 
sessions and HIIT sessions. 
Timing: 4-6 weeks prior to 
surgery.  
Type: endurance cycle 
ergometry 
19 patients undergoing 
lung resection for 
suspected malignancy 
were planned to 
complete baseline to 
pre-surgery 
intervention.  
 
9 patients will full data 
set 
 
Lung cancer 
QoL  
2 month 
post-
surgery 
0% Subset 
analysis 
 
Pre-surgical exercise training improved cardiorespiratory fitness, it did not seem to 
improve QOL from baseline to pre-surgery or mitigate the decline in QOL after 
surgery. 
QoL might be influenced by several other factors for exercise to have a meaningful 
effect. VO2 Peak did improve. 
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Comparator Individually 
tailored intervention and 
hospital based over 4-6 
weeks 
 
Sekine, 2005 
Prospective 
study with 
usual care 
control 
Frequency: 5x per day 
Intensity: moderate 
Timing: 2 weeks prior to 
surgery 
Type: 
1. Incentive spirometry 
2. Abdominal breathing 
and breathing exercises 
3. Bronchodilators 5x per 
day 
4. Huffing and coughing 
exercises 
5. 5000 steps per day 
 
Comparator historical 
control group of 60 patients 
without COPD 
 
N=82 (control=60) 
Rehab (n=22) 
 
(rehab group had more 
airflow obstruction 
FEV1/FVC) 
 
22 patients with COPD. 
 
Lung cancer 
30 days’ 
post 
operation 
 
1 month 
post-op 
0% 
Not reported 
The change in lung function as less diminished in the intervention group (p=0.023) 
 
Post-operative pulmonary complications there were no differences 
 
Postoperative hospital stays were significantly longer in the control group (p=0.003) 
equivalent to -6.8 days 
 
Study does not mathematically control for the differences between groups re baseline 
health. Study is underpowered 
 
Less decrease in pulmonary function (FEV1 and predicted decrease post-op) in 
Rehab group but overall pulmonary function was lower in this group. Note: This is 
probably because this group had COPD whereas the controls didn’t. 
 
Post-op stay was longer in the control group 
Sueppel, 2001 
Descriptive 
quasi-
experimental  
Frequency: Daily 
Intensity: Low 
Timing: Several weeks prior 
and night before surgery 
 
Type: Pelvic floor exercises.  
Pelvic floor muscle 
strengthening exercises pre-
op with biofeedback 
confirmation of correct 
performance, then continue 
PMEs  
 
Comparator: PMEs via 
video, then first biofeedback 
at 6 weeks video for pelvic 
floor muscle exercises, 
written instructions, nurse 
verbal support 
16 men pre pre-radical 
prostatectomy  
8 men per group 
 
Prostate cancer 
 
 
Assessm
ent at 
3,6,9,12 
months  
Not reported Analysis descriptive no statistical evidence, study underpowered and not controlled. 
Poorly reported study. 
 
Strengths: consistency of biofeedback instruction by same nurse 
Limitations: missing data, small sample size; don’t know prior voiding patterns of 
patients 
 
Overall some pre-op information while all other studies have been done post-op 
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Table 4. Prehabilitation RCT studies with statistically significant outcomes at 30 Days post 
treatment 
 
 
Prehabilitation RCT studies with statistically significant outcomes at 30 Days post treatment
Ref Physical functioning
Tumour type Objective Nutrition Patient reported outcome Service benefit
G
ai
t: 
6M
W
T
V
02
 P
ea
k
G
rip
 S
tre
ng
th
FE
V
1*
Pa
d 
us
ag
e*
C
H
A
M
PS
SF
36
 P
hy
si
ca
l f
un
ct
io
n
SF
36
 R
ol
e 
sc
al
es
 a
nd
 so
ci
al
 fu
nc
tio
n
B
M
I
Se
lf 
re
po
rt 
di
et
 
SF
36
 m
en
ta
l c
om
po
ne
nt
Pa
in
 s
co
re
s*
H
A
D
s
ST
A
I
PO
M
s
FA
C
T-
L *
IC
S 
m
al
e 
SF
*
LO
S
Le
ss
 h
os
pi
ta
lis
at
io
n 
Pt
 sa
tis
fa
ct
io
n
Fe
w
er
 c
om
pl
ic
at
io
ns
Bales 2000 Prostate cancer NS
Barlesi 2008 NSCLC NS
Burgio 2006 Prostate cancer +ve
Carli 2010 Colorectal cancer NS NS
Centemero 2010 Prostate cancer +ve +ve
Cheville 2015 GI and gall bladder +ve
Garssen 2013 Breast cancer NS +ve NS
Gillis 2014 Colorectal cancer +ve NS NS NS NS
Gillis 2015 Colorectal cancer NS NS NS NS NS
Jensen 2014 Bladder cancer NS
Jensen 2015 Bladder cancer NS NS
Moriya 2015 Colorectal cancer NS +ve
Parker 2009 Prostate cancer +ve NS
Schmidt 2015
GI , GU and thoracic 
cancers +ve NS NS
Stefanelli 2013 NSCLC with COPD +ve NS NS NS
VanBokhorst 2000 Head and Neck 
* Measures targeted to specific diseases or health problems   outcomes (+ve )significance >p0.005 (NS)not significant
Perceived 
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